圣诺生物
(688117)
| 流通市值：52.73亿 | | | 总市值：52.73亿 |
| 流通股本：2.20亿 | | | 总股本：2.20亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 507,264,016.25 | 244,285,419.6 | 741,455,412.91 | 520,117,203.2 |
| 营业收入 | 507,264,016.25 | 244,285,419.6 | 741,455,412.91 | 520,117,203.2 |
| 二、营业总成本 | 345,667,060.76 | 163,148,884.28 | 531,183,098.66 | 371,578,612.66 |
| 营业成本 | 209,330,378.89 | 98,035,946.4 | 313,970,217.93 | 225,369,839.38 |
| 税金及附加 | 6,241,620.71 | 2,937,448.05 | 6,323,690.33 | 5,012,187.69 |
| 销售费用 | 49,923,014.93 | 29,126,238.53 | 57,719,673.97 | 41,979,288.93 |
| 管理费用 | 45,491,303.42 | 17,818,851.38 | 81,303,526.1 | 51,746,145.86 |
| 研发费用 | 24,233,920.33 | 10,847,441.25 | 54,907,464.77 | 36,356,680 |
| 财务费用 | 10,446,822.48 | 4,382,958.67 | 16,958,525.56 | 11,114,470.8 |
| 其中:利息费用 | 9,923,847.46 | 6,451,243.61 | 17,534,063.83 | 12,273,533.78 |
| 其中:利息收入 | 3,453,155.75 | 1,596,939.96 | 1,500,297.77 | 1,281,980.34 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | - | - | 248,900 | -157,000 |
| 加:投资收益 | 31,808.5 | 341,449.32 | 1,955,306.77 | 1,055,691 |
| 资产处置收益 | -70,427.76 | -70,427.76 | - | - |
| 资产减值损失(新) | -5,858,242.39 | -4,675,622.67 | -14,873,082.1 | -9,320,522.86 |
| 信用减值损失(新) | -687,556.47 | -1,772,004.33 | -3,761,230.02 | 3,675,902.78 |
| 其他收益 | 2,542,725.58 | 1,124,655.86 | 8,108,852.06 | 3,712,631.74 |
| 四、营业利润 | 157,555,262.95 | 76,084,585.74 | 201,951,060.96 | 147,505,293.2 |
| 加:营业外收入 | 7,805.91 | - | 47,598.34 | 34,885.77 |
| 减:营业外支出 | 187,567.77 | 100,542.56 | 12,869,246.96 | 1,864,105.42 |
| 五、利润总额 | 157,375,501.09 | 75,984,043.18 | 189,129,412.34 | 145,676,073.55 |
| 减:所得税费用 | 22,181,490.88 | 9,621,810.5 | 31,239,474.99 | 18,704,742.35 |
| 六、净利润 | 135,194,010.21 | 66,362,232.68 | 157,889,937.35 | 126,971,331.2 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 135,194,010.21 | 66,362,232.68 | 157,889,937.35 | 126,971,331.2 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 135,194,010.21 | 66,362,232.68 | 157,924,373.41 | 127,010,169.16 |
| 少数股东损益 | - | - | -34,436.06 | -38,837.96 |
| 扣除非经常损益后的净利润 | 134,380,220.75 | 65,873,031.19 | 164,802,282.07 | 126,074,692.07 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.61 | 0.42 | 1 | 0.81 |
| (二)稀释每股收益 | 0.61 | 0.42 | 1 | 0.8 |
| 九、综合收益总额 | 135,194,010.21 | 66,362,232.68 | 157,889,937.35 | 126,971,331.2 |
| 归属于母公司股东的综合收益总额 | 135,194,010.21 | 66,362,232.68 | 157,924,373.41 | 127,010,169.16 |
| 归属于少数股东的综合收益总额 | - | - | -34,436.06 | -38,837.96 |
| 公告日期 | 2026-08-20 | 2026-04-24 | 2026-04-24 | 2025-10-28 |
| 审计意见(境内) | | | 标准无保留意见 | |